Effectiveness of iodine-impregnated incise drapes for preventing surgical site infection in patients with clean or clean contaminated wounds: A systematic literature review and cost-consequence analysis.

Cost-consequence analysis Infection control Iodine-impregnated incise drapes Surgical site infection Systematic review

Journal

Journal of perioperative practice
ISSN: 2515-7949
Titre abrégé: J Perioper Pract
Pays: England
ID NLM: 101271023

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 4 12 2023
pubmed: 28 1 2023
entrez: 27 1 2023
Statut: ppublish

Résumé

Surgical site infection is a serious complication associated with significant morbidity, mortality and health care expenditure. To determine the clinical effectiveness and economic impact of using iodine-impregnated incise drapes for preventing surgical site infection. MEDLINE, Embase, Cochrane Library and CINAHL databases were systematically searched. Critical appraisal and synthesis of clinical evidence informed a decision analytical cost-consequence model. Nine studies were included in the systematic literature review. Evidence from cardiac surgery patients was considered appropriate to inform the cost analysis. The economic model evaluation estimated cost savings of £549 per patient with the iodophor-impregnated drape in the deterministic analysis and a mean cost saving per patient of £554,172 per 1000 in the probabilistic analysis. Using iodine-impregnated drapes in cardiac surgery patients may effectively reduce infections and provide cost-savings, but further research is required.

Sections du résumé

BACKGROUND UNASSIGNED
Surgical site infection is a serious complication associated with significant morbidity, mortality and health care expenditure.
AIMS UNASSIGNED
To determine the clinical effectiveness and economic impact of using iodine-impregnated incise drapes for preventing surgical site infection.
METHODS UNASSIGNED
MEDLINE, Embase, Cochrane Library and CINAHL databases were systematically searched. Critical appraisal and synthesis of clinical evidence informed a decision analytical cost-consequence model.
FINDINGS UNASSIGNED
Nine studies were included in the systematic literature review. Evidence from cardiac surgery patients was considered appropriate to inform the cost analysis. The economic model evaluation estimated cost savings of £549 per patient with the iodophor-impregnated drape in the deterministic analysis and a mean cost saving per patient of £554,172 per 1000 in the probabilistic analysis.
CONCLUSION UNASSIGNED
Using iodine-impregnated drapes in cardiac surgery patients may effectively reduce infections and provide cost-savings, but further research is required.

Identifiants

pubmed: 36705002
doi: 10.1177/17504589221139603
pmc: PMC10693728
doi:

Substances chimiques

Iodine 9679TC07X4

Types de publication

Systematic Review Journal Article Review

Langues

eng

Pagination

368-379

Références

Aust N Z J Surg. 1987 Nov;57(11):859-63
pubmed: 3326567
J Hosp Infect. 2014 Jan;86(1):24-33
pubmed: 24268456
Evid Based Med. 2017 Jun;22(3):85-87
pubmed: 28320705
Biomed Res Int. 2019 Feb 11;2019:1438793
pubmed: 30886857
J Hosp Infect. 2017 May;96(1):1-15
pubmed: 28410761
Lancet Infect Dis. 2016 Dec;16(12):e276-e287
pubmed: 27816413
Clin Orthop Relat Res. 1988 Mar;(228):307-8
pubmed: 3342583
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Am Surg. 2017 Jun 1;83(6):617-622
pubmed: 28637564
Infect Control Hosp Epidemiol. 2014 Jun;35(6):605-27
pubmed: 24799638
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Surg Infect (Larchmt). 2008 Feb;9(1):23-32
pubmed: 18363465
J Arthroplasty. 2018 Jun;33(6):1891-1895
pubmed: 29525345
Cochrane Database Syst Rev. 2015 Apr 22;(4):CD006353
pubmed: 25901509
AORN J. 2002 Nov;76(5):821-8
pubmed: 12463081
Childs Nerv Syst. 2012 Apr;28(4):509-10
pubmed: 22354120
JAMA Surg. 2017 Aug 01;152(8):784-791
pubmed: 28467526
Cochrane Database Syst Rev. 2018 Feb 06;2:CD012653
pubmed: 29406579
World J Surg. 2003 Jun;27(6):685-8
pubmed: 12732986
J Cardiovasc Transl Res. 2015 Oct;8(7):431-7
pubmed: 26374143
BMJ. 2020 Jan 16;368:l6890
pubmed: 31948937
Clin Orthop Relat Res. 2020 May;478(5):1007-1015
pubmed: 32011378

Auteurs

Katie Sworn (K)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.

Edith Poku (E)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.

Praveen Thokala (P)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.

Anthea Sutton (A)

School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.

Steve Foster (S)

3M UK PLC, Loughborough, UK.

Ian Siddall (I)

3M UK PLC, Loughborough, UK.

Henning Reuter (H)

Medical Solutions Division, 3M Deutschland GmbH, Neuss, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH